Evidence map›Paper›PMID 39643658›Full record

ReviewStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2025

Navigating through recent evidence on locoregional breast cancer radiotherapy: an initiative by the scientific association of Swiss radiation oncology.

Pelagia G Tsoutsou, Anna-Lena Eberhardt, Günther Gruber, Guido Henke, Wendy Jeannerret-Sozzi, Claudia Linsenmeier, Kristina Lössl, Maria-Carla Valli, Walter P Weber, Kathrin Zaugg and 2 more

Abstract readReview
In one paragraph

Review in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pelagia G TsoutsouRadiation Oncology Department, Geneva University Hospitals (HUG) and Faculty of Medicine, University of Geneva (UNIGE), Avenue de la Roseraie 53, 1205, Geneva, Switzerland. Pelagia.Tsoutsou@hug.ch.ORCID 0000-0002-6490-9278
Anna-Lena EberhardtRadiation Oncology Department, University Hospital Basel (USB), Basel, Switzerland.
Günther GruberRadiation Oncology Department, Hirslanden Zurich, Zurich, Switzerland.
Guido HenkeRadiation Oncology Department, Team Radiology Plus, Münsterlingen, Switzerland.
Wendy Jeannerret-SozziRadiation Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Claudia LinsenmeierRadiation Oncology Department, Zurich University Hospital (USZ), Zurich, Switzerland.
Kristina LösslRadiation Oncology Department, Inselsital, Bern University Hospital, University of Bern, Bern, Switzerland.
Maria-Carla ValliRadiation Oncology Department, Bellinzona Hospital (IOSI), Bellinzona, Switzerland.
Walter P WeberBreast Cancer Surgery Department, Basel University Hospital (USB), Basel, Switzerland.
Kathrin ZauggRadiation Oncology Department, Stadtspital Zürich, Zürich, Switzerland.
Khalil ZamanMedical Oncology Service, Lausanne University Hospital CHUV, Lausanne, Switzerland.
Daniel ZwahlenRadiation Oncology Department, Winterthur Cantonal Hospital, Winterthur, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBreast cancer (BC) is the most prevalent cancer in women and radiotherapy (RT) is an integral part of its treatment. High-level evidence guides clinical decisions, but given the abundance of guidelines, a need to navigate within the evidence has been identified by the board of the Scientific Association of Swiss Radiation Oncology (SASRO). A pilot project was initiated aiming to create an overview of recent clinically relevant evidence for BC RT, to make it easily available to (radiation) oncologists and radiation oncologists in training.

methodsA panel of 10 radiation oncology experts for BC RT, one expert in BC surgery, and one expert in BC medical oncology critically reviewed the relevant literature. The panel comprehensively represented different geographical regions of Switzerland as well as university, cantonal, and private institutions. We sought to create a consensual overview of the most relevant questions in BC RT today, accompanied by the most recent and relevant available evidence.

resultsFrom January 2023 to January 2024, the panel met four times to review and work on an initial draft. The final draft was reviewed and accepted by all panelists. We hereby publish this work to make it available to international audiences. After publication, the work will be made available to all SASRO members on the SASRO website. This work is to be updated every 2 years.

conclusionThe identified need was addressed with a successful pilot project and will be further expanded upon in other tumor pathologies.

Indexed as

Breast NeoplasmsRadiation OncologyEvidence-Based MedicineFemaleHumansPilot ProjectsSwitzerlandEducationEvidenceEvidence-based practiceGuidelinesTool

Identifiers

PMID39643658
PMCPMC11754371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.